The agency began investigating a potential link after reports of blood clots emerged in several countries, with some researchers finding young women at particular risk for thrombosis, a potentially dangerous condition in which blood clots can clog. circulation after receiving the vaccine.
Several countries across the block suspended use of AstraZeneca in mid-March, but resumed it after the EMA said the vaccine was still safe to use after an initial review of relevant data.
However, Germany then ditched AstraZeneca at the end of March, limiting its use to people over the age of 60 amid persistent safety concerns.
The highest health authority in France also recommends vaccination with AstraZeneca only for people over 55 years old.
Marco Cavaleri, the head of the vaccination service at the EMA, told Italian newspaper Il Messaggero in an interview published on Tuesday that, according to his own assessment, there was a link between incidents of blood clots in the brain and vaccinations AstraZeneca which had not yet taken place. been determined more precisely.
EU health ministers will meet in a video conference to discuss the EMA’s findings in the evening. (dpa / NAN)
Short Link: https://wp.me/pcj2iU-3yFz
- Correctional center controller recommends amnesty for some inmates
- Society defines May 5 as National Bible Day
- SEC instructs CMOs to update investor information
- Coronavirus – Zambia: COVID-19 update (April 14, 2021)
- FG distributes inputs to 7,500 women farmers
- Intelligence gathering is key to resolving insurgency -GOC
- Coronavirus – Namibia: COVID-19 update (April 14, 2021)
- More than one million confirmed COVID-19 deaths in Europe – WHO
- Broadband is crucial for Nigeria’s economic growth – Osinbajo